首页 > 最新文献

Epilepsy Currents最新文献

英文 中文
It Matters Who Starts the Fire in Mesial Temporal Lobe Epilepsy 中颞叶癫痫的起火者很重要
IF 3.6 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-04-17 DOI: 10.1177/15357597241238901
Jeffrey H. Goodman
[Box: see text]
[方框:见正文]
{"title":"It Matters Who Starts the Fire in Mesial Temporal Lobe Epilepsy","authors":"Jeffrey H. Goodman","doi":"10.1177/15357597241238901","DOIUrl":"https://doi.org/10.1177/15357597241238901","url":null,"abstract":"[Box: see text]","PeriodicalId":11742,"journal":{"name":"Epilepsy Currents","volume":"200 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140617315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
It’s About Time! Timing in Epilepsy Evaluation and Treatment 是时候了癫痫评估和治疗的时机
IF 3.6 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-04-01 DOI: 10.1177/15357597241238072
Heather Ravvin McKee, Jorge Vidaurre, Dave Clarke, Janelle Wagner, Jeffrey W. Britton, Linda Laux, Eugen Trinka, Clio Rubinos, Tanya J. W. McDonald, Fred A. Lado, Martina Bebin, Christos Papadelis, Aaron F. Struck, Carolina B. Maciel, Ana L. Velasco, Arjun Chandran, Sandipan Pati, Nitin Tandon, Guadalupe Fernandez-Baca Vaca, Madison M. Berl, Ahsan N. Moosa
The 2023 American Epilepsy Society Annual Course “It’s About Time” addressed timing in epilepsy evaluation and treatment with respect to health disparity and vulnerable populations and diagnostic, clinical, and epilepsy surgery evaluation. This comprehensive course included topics on gaps in epilepsy care and optimization of behavioral health for patients with epilepsy. The summary details current knowledge in areas of seizure forecasting and epileptogenesis. Intricacies and controversies over timing were discussed for treatment of nonconvulsive seizures and ictal-interictal patterns, acute symptomatic seizures, neuromodulation versus surgery, and epilepsy surgery in status epilepticus. Timing regarding clinical care in autoimmune-associated epilepsy, developmental and epileptic encephalopathy, and dietary therapy were examined. Additionally, salient topics on using novel biomarkers and collaboration with neuropsychological outcomes were also tackled in this all-encompassing lecture series.
2023 年美国癫痫协会年度课程 "是时候了 "探讨了癫痫评估和治疗的时机,涉及健康差异和弱势群体,以及诊断、临床和癫痫手术评估。该综合课程包括癫痫护理中的差距和优化癫痫患者行为健康等主题。摘要详细介绍了癫痫发作预测和癫痫发生领域的最新知识。会议讨论了非惊厥性癫痫发作和发作间期模式、急性症状性癫痫发作、神经调控与手术以及癫痫状态手术治疗时机的复杂性和争议。会议还探讨了自身免疫相关性癫痫、发育性癫痫和癫痫性脑病的临床治疗时机以及饮食疗法。此外,在这个包罗万象的系列讲座中,还探讨了使用新型生物标志物和与神经心理学成果合作的突出问题。
{"title":"It’s About Time! Timing in Epilepsy Evaluation and Treatment","authors":"Heather Ravvin McKee, Jorge Vidaurre, Dave Clarke, Janelle Wagner, Jeffrey W. Britton, Linda Laux, Eugen Trinka, Clio Rubinos, Tanya J. W. McDonald, Fred A. Lado, Martina Bebin, Christos Papadelis, Aaron F. Struck, Carolina B. Maciel, Ana L. Velasco, Arjun Chandran, Sandipan Pati, Nitin Tandon, Guadalupe Fernandez-Baca Vaca, Madison M. Berl, Ahsan N. Moosa","doi":"10.1177/15357597241238072","DOIUrl":"https://doi.org/10.1177/15357597241238072","url":null,"abstract":"The 2023 American Epilepsy Society Annual Course “It’s About Time” addressed timing in epilepsy evaluation and treatment with respect to health disparity and vulnerable populations and diagnostic, clinical, and epilepsy surgery evaluation. This comprehensive course included topics on gaps in epilepsy care and optimization of behavioral health for patients with epilepsy. The summary details current knowledge in areas of seizure forecasting and epileptogenesis. Intricacies and controversies over timing were discussed for treatment of nonconvulsive seizures and ictal-interictal patterns, acute symptomatic seizures, neuromodulation versus surgery, and epilepsy surgery in status epilepticus. Timing regarding clinical care in autoimmune-associated epilepsy, developmental and epileptic encephalopathy, and dietary therapy were examined. Additionally, salient topics on using novel biomarkers and collaboration with neuropsychological outcomes were also tackled in this all-encompassing lecture series.","PeriodicalId":11742,"journal":{"name":"Epilepsy Currents","volume":"34 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140603053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence: Fundamentals and Breakthrough Applications in Epilepsy 人工智能:癫痫的基础知识和突破性应用
IF 3.6 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-04-01 DOI: 10.1177/15357597241238526
Wesley Kerr, Sandra Acosta, Patrick Kwan, Gregory Worrell, Mohamad A. Mikati
Artificial intelligence, machine learning, and deep learning are increasingly being used in all medical fields including for epilepsy research and clinical care. Already there have been resultant cutting-edge applications in both the clinical and research arenas of epileptology. Because there is a need to disseminate knowledge about these approaches, how to use them, their advantages, and their potential limitations, the goal of the 2023 Merritt-Putnam Symposium and of this synopsis review of that symposium has been to present the background and state of the art and then to draw conclusions on current and future applications of these approaches through the following: (1) Initially provide an explanation of the fundamental principles of artificial intelligence, machine learning, and deep learning. These are presented in the first section of this review by Dr Wesley Kerr. (2) Provide insights into their cutting-edge applications in screening for medications in neural organoids, in general, and for epilepsy in particular. These are presented by Dr Sandra Acosta. (3) Provide insights into how artificial intelligence approaches can predict clinical response to medication treatments. These are presented by Dr Patrick Kwan. (4) Finally, provide insights into the expanding applications to the detection and analysis of EEG signals in intensive care, epilepsy monitoring unit, and intracranial monitoring situations, as presented below by Dr Gregory Worrell. The expectation is that, in the coming decade and beyond, the increasing use of the above approaches will transform epilepsy research and care and supplement, but not replace, the diligent work of epilepsy clinicians and researchers.
人工智能、机器学习和深度学习正越来越多地应用于所有医学领域,包括癫痫研究和临床护理。在癫痫病学的临床和研究领域,已经有了尖端的应用成果。由于需要传播有关这些方法、如何使用这些方法、它们的优势和潜在局限性的知识,2023 年梅里特-普特南研讨会和本研讨会综述的目标是介绍这些方法的背景和技术现状,然后通过以下内容得出这些方法当前和未来应用的结论:(1) 首先解释人工智能、机器学习和深度学习的基本原理。Wesley Kerr 博士在本综述的第一部分介绍了这些原理。(2) 深入探讨它们在神经器官组织中筛选药物的前沿应用,特别是癫痫。Sandra Acosta 博士将对此进行介绍。(3) 深入探讨人工智能方法如何预测药物治疗的临床反应。Patrick Kwan 博士将对此进行介绍。(4) 最后,由 Gregory Worrell 博士介绍在重症监护、癫痫监测单元和颅内监测情况下检测和分析脑电信号的不断扩展应用。我们期望,在未来十年及以后,上述方法的日益广泛应用将改变癫痫研究和护理,补充而不是取代癫痫临床医生和研究人员的辛勤工作。
{"title":"Artificial Intelligence: Fundamentals and Breakthrough Applications in Epilepsy","authors":"Wesley Kerr, Sandra Acosta, Patrick Kwan, Gregory Worrell, Mohamad A. Mikati","doi":"10.1177/15357597241238526","DOIUrl":"https://doi.org/10.1177/15357597241238526","url":null,"abstract":"Artificial intelligence, machine learning, and deep learning are increasingly being used in all medical fields including for epilepsy research and clinical care. Already there have been resultant cutting-edge applications in both the clinical and research arenas of epileptology. Because there is a need to disseminate knowledge about these approaches, how to use them, their advantages, and their potential limitations, the goal of the 2023 Merritt-Putnam Symposium and of this synopsis review of that symposium has been to present the background and state of the art and then to draw conclusions on current and future applications of these approaches through the following: (1) Initially provide an explanation of the fundamental principles of artificial intelligence, machine learning, and deep learning. These are presented in the first section of this review by Dr Wesley Kerr. (2) Provide insights into their cutting-edge applications in screening for medications in neural organoids, in general, and for epilepsy in particular. These are presented by Dr Sandra Acosta. (3) Provide insights into how artificial intelligence approaches can predict clinical response to medication treatments. These are presented by Dr Patrick Kwan. (4) Finally, provide insights into the expanding applications to the detection and analysis of EEG signals in intensive care, epilepsy monitoring unit, and intracranial monitoring situations, as presented below by Dr Gregory Worrell. The expectation is that, in the coming decade and beyond, the increasing use of the above approaches will transform epilepsy research and care and supplement, but not replace, the diligent work of epilepsy clinicians and researchers.","PeriodicalId":11742,"journal":{"name":"Epilepsy Currents","volume":"37 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140573463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exit Strategy: Balancing the Risks and Rewards of Antiseizure Medication Withdrawal 退出策略:平衡停用抗癫痫药物的风险与回报
IF 3.6 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-03-25 DOI: 10.1177/15357597241238898
Marian Galovic, Carolina Ferreira-Atuesta, Lara E. Jehi, Kees P. J. Braun, Samuel W. Terman
The majority of people with epilepsy achieves long-term seizure-freedom and may consider withdrawal of their anti-seizure medications (ASMs). Withdrawal of ASMs can yield substantial benefits but may be associated with potential risks. This review critically examines the existing literature on ASM withdrawal, emphasizing evidence-based recommendations, where available. Our focus encompasses deprescribing strategies for individuals who have attained seizure freedom through medical treatment, those who have undergone successful epilepsy surgery, and individuals initiated on ASMs following acute symptomatic seizures. We explore state-of-the-art prognostic models in these scenarios that could guide the decision-making process. The review underscores the importance of a collaborative shared-decision approach between patients, caregivers, and physicians. We describe the subjective and objective factors influencing these decisions and illustrate how trade-offs may be effectively managed in practice.
大多数癫痫患者在长期摆脱癫痫发作后可能会考虑停用抗癫痫药物(ASMs)。停用抗癫痫药物可带来巨大益处,但也可能存在潜在风险。本综述对有关 ASM 停药的现有文献进行了严格审查,并强调了以证据为基础的建议(如有)。我们关注的重点包括通过药物治疗获得癫痫发作自由的患者、成功接受癫痫手术的患者以及在急性症状性癫痫发作后开始使用 ASMs 的患者的停药策略。我们探讨了这些情况下可指导决策过程的最新预后模型。综述强调了患者、护理人员和医生之间合作共享决策方法的重要性。我们描述了影响这些决策的主观和客观因素,并说明了如何在实践中有效地权衡利弊。
{"title":"Exit Strategy: Balancing the Risks and Rewards of Antiseizure Medication Withdrawal","authors":"Marian Galovic, Carolina Ferreira-Atuesta, Lara E. Jehi, Kees P. J. Braun, Samuel W. Terman","doi":"10.1177/15357597241238898","DOIUrl":"https://doi.org/10.1177/15357597241238898","url":null,"abstract":"The majority of people with epilepsy achieves long-term seizure-freedom and may consider withdrawal of their anti-seizure medications (ASMs). Withdrawal of ASMs can yield substantial benefits but may be associated with potential risks. This review critically examines the existing literature on ASM withdrawal, emphasizing evidence-based recommendations, where available. Our focus encompasses deprescribing strategies for individuals who have attained seizure freedom through medical treatment, those who have undergone successful epilepsy surgery, and individuals initiated on ASMs following acute symptomatic seizures. We explore state-of-the-art prognostic models in these scenarios that could guide the decision-making process. The review underscores the importance of a collaborative shared-decision approach between patients, caregivers, and physicians. We describe the subjective and objective factors influencing these decisions and illustrate how trade-offs may be effectively managed in practice.","PeriodicalId":11742,"journal":{"name":"Epilepsy Currents","volume":"279 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140300649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic Testing in Epilepsy: Improving Outcomes and Informing Gaps in Research 癫痫基因检测:提高研究成果,填补研究空白
IF 3.6 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-03-25 DOI: 10.1177/15357597241232881
Christa W. Habela, Krista Schatz, Sarah A. Kelley
While the diagnosis of epilepsy relies on the presence of seizures, it encompasses a group of phenotypically and etiologically diverse disorders in which seizures may only be one of a constellation of symptoms. There are genetic, structural, and metabolic causes, but most epilepsy syndromes have some genetic predisposition. The importance of genetics in the diagnosis and management of epilepsy has been increasingly recognized over the past 2 decades. With increased access to testing tools and new recommendations that all patients with unexplained epilepsy get genetic testing, it is becoming part of routine clinical care. Increased testing has resulted in an explosion in the number of genes and genetic changes identified and it is changing our understanding of the mechanisms of epileptogenesis. Advances in both clinical genetics and scientific discovery are expanding our potential to impact patient care as well as creating dilemmas. This brief review will highlight where we are regarding our ability to obtain a genetic diagnosis, how diagnoses impact patient care, and the next likely frontiers in diagnosis and management.
虽然癫痫的诊断依赖于癫痫发作的出现,但它包括一组表型和病因各异的疾病,其中癫痫发作可能只是一系列症状中的一种。有遗传、结构和代谢原因,但大多数癫痫综合征都有一定的遗传倾向。过去二十年来,遗传学在癫痫诊断和治疗中的重要性日益得到认可。随着检测工具的普及和所有不明原因癫痫患者接受基因检测的新建议,基因检测正成为常规临床护理的一部分。检测的增加导致已确定的基因和基因变化的数量激增,也改变了我们对癫痫发生机制的认识。临床遗传学和科学发现的进步正在扩大我们影响患者护理的潜力,同时也带来了困境。这篇简短的综述将重点介绍我们目前获得基因诊断的能力、诊断对患者护理的影响以及诊断和管理的下一个可能的前沿领域。
{"title":"Genetic Testing in Epilepsy: Improving Outcomes and Informing Gaps in Research","authors":"Christa W. Habela, Krista Schatz, Sarah A. Kelley","doi":"10.1177/15357597241232881","DOIUrl":"https://doi.org/10.1177/15357597241232881","url":null,"abstract":"While the diagnosis of epilepsy relies on the presence of seizures, it encompasses a group of phenotypically and etiologically diverse disorders in which seizures may only be one of a constellation of symptoms. There are genetic, structural, and metabolic causes, but most epilepsy syndromes have some genetic predisposition. The importance of genetics in the diagnosis and management of epilepsy has been increasingly recognized over the past 2 decades. With increased access to testing tools and new recommendations that all patients with unexplained epilepsy get genetic testing, it is becoming part of routine clinical care. Increased testing has resulted in an explosion in the number of genes and genetic changes identified and it is changing our understanding of the mechanisms of epileptogenesis. Advances in both clinical genetics and scientific discovery are expanding our potential to impact patient care as well as creating dilemmas. This brief review will highlight where we are regarding our ability to obtain a genetic diagnosis, how diagnoses impact patient care, and the next likely frontiers in diagnosis and management.","PeriodicalId":11742,"journal":{"name":"Epilepsy Currents","volume":"30 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140300497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteoporosis: The Brittle Reality of an Epilepsy Diagnosis 骨质疏松症:癫痫诊断的脆弱现实
IF 3.6 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-03-25 DOI: 10.1177/15357597241238532
Shruti Agashe
[Box: see text]
[方框:见正文]
{"title":"Osteoporosis: The Brittle Reality of an Epilepsy Diagnosis","authors":"Shruti Agashe","doi":"10.1177/15357597241238532","DOIUrl":"https://doi.org/10.1177/15357597241238532","url":null,"abstract":"[Box: see text]","PeriodicalId":11742,"journal":{"name":"Epilepsy Currents","volume":"1 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140300531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Getting Excited About Chloride Cotransporters: Neuroinflammation and Inhibition 令人兴奋的氯化物共转运体:神经炎症与抑制
IF 3.6 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-03-25 DOI: 10.1177/15357597241238893
Punam A. Sawant-Pokam, Cameron S. Metcalf
[Box: see text]
[方框:见正文]
{"title":"Getting Excited About Chloride Cotransporters: Neuroinflammation and Inhibition","authors":"Punam A. Sawant-Pokam, Cameron S. Metcalf","doi":"10.1177/15357597241238893","DOIUrl":"https://doi.org/10.1177/15357597241238893","url":null,"abstract":"[Box: see text]","PeriodicalId":11742,"journal":{"name":"Epilepsy Currents","volume":"46 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140300474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapid Whole Genome Sequencing: It Is Feasible! When Can We Implement It? 快速全基因组测序:它是可行的!何时才能实现?
IF 3.6 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-03-25 DOI: 10.1177/15357597241237349
Charuta Joshi
[Box: see text]
[方框:见正文]
{"title":"Rapid Whole Genome Sequencing: It Is Feasible! When Can We Implement It?","authors":"Charuta Joshi","doi":"10.1177/15357597241237349","DOIUrl":"https://doi.org/10.1177/15357597241237349","url":null,"abstract":"[Box: see text]","PeriodicalId":11742,"journal":{"name":"Epilepsy Currents","volume":"24 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140301005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Of Hearth and Home: Professional Wellness After Hours 炉灶与家庭:下班后的专业健康
IF 3.6 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-03-18 DOI: 10.1177/15357597241237375
Timothy J. Ainger, Meriem Bensalem-Owen, Joanna Fong-Isariyawongse, Matthew William Luedke
Burnout is a prevalent problem in the contemporary practice of medicine. Defined by the Agency for Healthcare Research and Quality as, “a long-term stress reaction marked by emotional exhaustion, depersonalization, and a lack of sense of personal accomplishment,” this multifactorial condition has significant implications for the clinicians who suffer it, their patients, and families. Neurologists suffer some of the highest rates of burnout. Burnout research on interventions often focus on the work environment. In this article, we will focus on burnout’s effects on home life and features of home life that can impact resiliency, specifically sleep hygiene.
职业倦怠是当代医学界普遍存在的问题。医疗保健研究与质量机构将其定义为 "一种长期的压力反应,以情绪衰竭、人格解体和缺乏个人成就感为特征"。神经科医生是职业倦怠发生率最高的人群之一。有关职业倦怠干预措施的研究通常侧重于工作环境。在本文中,我们将重点讨论职业倦怠对家庭生活的影响,以及可能影响恢复能力的家庭生活特征,特别是睡眠卫生。
{"title":"Of Hearth and Home: Professional Wellness After Hours","authors":"Timothy J. Ainger, Meriem Bensalem-Owen, Joanna Fong-Isariyawongse, Matthew William Luedke","doi":"10.1177/15357597241237375","DOIUrl":"https://doi.org/10.1177/15357597241237375","url":null,"abstract":"Burnout is a prevalent problem in the contemporary practice of medicine. Defined by the Agency for Healthcare Research and Quality as, “a long-term stress reaction marked by emotional exhaustion, depersonalization, and a lack of sense of personal accomplishment,” this multifactorial condition has significant implications for the clinicians who suffer it, their patients, and families. Neurologists suffer some of the highest rates of burnout. Burnout research on interventions often focus on the work environment. In this article, we will focus on burnout’s effects on home life and features of home life that can impact resiliency, specifically sleep hygiene.","PeriodicalId":11742,"journal":{"name":"Epilepsy Currents","volume":"143 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140166436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Double, Double Toil and Trouble: Recurrent Episodes of Status Epilepticus Are Associated With Increasingly Worse Outcomes 双倍、双倍的辛劳和麻烦:癫痫状态反复发作与越来越差的预后有关
IF 3.6 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-03-18 DOI: 10.1177/15357597231223587
Nicolas Gaspard
[Box: see text]
[方框:见正文]
{"title":"Double, Double Toil and Trouble: Recurrent Episodes of Status Epilepticus Are Associated With Increasingly Worse Outcomes","authors":"Nicolas Gaspard","doi":"10.1177/15357597231223587","DOIUrl":"https://doi.org/10.1177/15357597231223587","url":null,"abstract":"[Box: see text]","PeriodicalId":11742,"journal":{"name":"Epilepsy Currents","volume":"22 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140166468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Epilepsy Currents
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1